Hepatitis Monthly

Published by: Kowsar

Epidemiological, Virological and Clinical Characteristics of Hepatitis B Virus Genotypes in Chronically Infected Persons in Slovenia

Nina Kmet Lunacek 1 , * , Mario Poljak 2 , Jelka Meglic-Volkar 1 , Mojca Rajter 1 , Janja Prah 1 , Gorazd Lesnicar 3 , Tanja Selic Kurincic 3 , Zvonko Baklan 4 , Tatajana Remec 5 , Emil Pal 6 , Petra Markocic 2 , Maja Lunar 2 and Mojca Maticic 1
Authors Information
1 Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Slovenia
2 Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Slovenia
3 Department of Infectious Diseases and Febrile Conditions, General Hospital Celje, Slovenia
4 Department of Infectious Diseases and Febrile Illnesses, University Clinical Centre Maribor, Slovenia
5 General Hospital Novo mesto, Slovenia
6 General Hospital Murska Sobota, Slovenia
Article information
  • Hepatitis Monthly: March 01, 2017, 17 (3); e43838
  • Published Online: March 4, 2017
  • Article Type: Rapid Communication
  • Received: December 12, 2016
  • Revised: February 12, 2017
  • Accepted: February 14, 2017
  • DOI: 10.5812/hepatmon.43838

To Cite: Kmet Lunacek N, Poljak M, Meglic-Volkar J, Rajter M, Prah J, et al. Epidemiological, Virological and Clinical Characteristics of Hepatitis B Virus Genotypes in Chronically Infected Persons in Slovenia, Hepat Mon. 2017 ; 17(3):e43838. doi: 10.5812/hepatmon.43838.

Abstract
Copyright © 2017, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
References
  • 1. Locarnini S, Hatzakis A, Chen DS, Lok A. Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs. J Hepatol. 2015; 62(1 Suppl)-86[DOI][PubMed]
  • 2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2095-128[DOI][PubMed]
  • 3. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015; 386(10003): 1546-55[DOI][PubMed]
  • 4. Sunbul M. Hepatitis B virus genotypes: global distribution and clinical importance. World J Gastroenterol. 2014; 20(18): 5427-34[DOI][PubMed]
  • 5. Hatzakis A, Van Damme P, Alcorn K, Gore C, Benazzouz M, Berkane S, et al. The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference. J Viral Hepat. 2013; 20 Suppl 2: 1-20[DOI][PubMed]
  • 6. Kraigher A, Socan, M. , Klavs, I. , Frelih, T. , Grilc, E. , Grgic Vitek, M. . Epidemiological surveillance of communicable diseases in Slovenia in 2013. 2014;
  • 7. Friedman SL. Focus. Metchnikoff, macrophages and the metabolic syndrome. J Hepatol. 2012; 57(1): 1-2[DOI][PubMed]
  • 8. Malmstrom S, Berglin-Enquist I, Lindh M. Novel method for genotyping hepatitis B virus on the basis of TaqMan real-time PCR. J Clin Microbiol. 2010; 48(4): 1105-11[DOI][PubMed]
  • 9. Osiowy C, Villeneuve JP, Heathcote EJ, Giles E, Borlang J. Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2). J Clin Microbiol. 2006; 44(6): 1994-7[DOI][PubMed]
  • 10. Beggel B, Neumann-Fraune M, Doring M, Lawyer G, Kaiser R, Verheyen J, et al. Genotyping hepatitis B virus dual infections using population-based sequence data. J Gen Virol. 2012; 93: 1899-907[DOI][PubMed]
  • 11. Agresti A. Building and applying logistic regression models. An introduction to categorical data analysis. 2007; : 137-62
  • 12. Baklan Z, Gorisek JR, Poljak M, Pisec A. Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor. Wien Klin Wochenschr. 2004; 116 Suppl 2: 5-7[PubMed]
  • 13. Prevalence of current hepatitis B infection (percentage with HBsAg) among injecting drug users (%), 1991 to 2007. 2009;
  • 14. Seme K, Lunar MM, Tomazic J, Vidmar L, Karner P, Maticic M, et al. Low prevalence of hepatitis B and C infections among HIV-infected individuals in Slovenia: a nation-wide study, 1986-2008. Acta Dermatovenerol Alp Pannonica Adriat. 2009; 18(4): 153-6[PubMed]
  • 15. Skamperle M, Seme K, Lunar MM, Maver PJ, Tomazic J, Vovko TD, et al. Prevalence, genotype distribution, and risk factors for hepatitis C infection among HIV-infected individuals in Slovenia: a 1986-2013 update. Acta Dermatovenerol Alp Pannonica Adriat. 2014; 23(2): 25-6[PubMed]
  • 16. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003; 362(9377): 22-9[PubMed]
  • 17. Lazarevic I, Cupic M, Delic D, Svirtlih NS, Simonovic J, Jovanovic T. Distribution of HBV genotypes, subgenotypes and HBsAg subtypes among chronically infected patients in Serbia. Arch Virol. 2007; 152(11): 2017-25[DOI][PubMed]
  • 18. Milosevic I, Delic D, Lazarevic I, Pavlovic IP, Korac M, Bojovic K, et al. The significance of hepatitis B virus (HBV) genotypes for the disease and treatment outcome among patients with chronic hepatitis B in Serbia. J Clin Virol. 2013; 58(1): 54-8[DOI][PubMed]
  • 19. Vratnica Z, Zehender G, Ebranati E, Sorrentino C, Lai A, Vujosevic D, et al. Hepatitis B virus genotype and subgenotype prevalence and distribution in Montenegro. J Med Virol. 2015; 87(5): 807-13[DOI][PubMed]
  • 20. Deterding K, Constantinescu I, Nedelcu FD, Gervain J, Nemecek V, Srtunecky O, et al. Prevalence of HBV genotypes in Central and Eastern Europe. J Med Virol. 2008; 80(10): 1707-11[DOI][PubMed]
  • 21. van Houdt R, Bruisten SM, Geskus RB, Bakker M, Wolthers KC, Prins M, et al. Ongoing transmission of a single hepatitis B virus strain among men having sex with men in Amsterdam. J Viral Hepat. 2010; 17(2): 108-14[DOI][PubMed]
  • 22. Koibuchi T, Hitani A, Nakamura T, Nojiri N, Nakajima K, Jyuji T, et al. Predominance of genotype A HBV in an HBV-HIV-1 dually positive population compared with an HIV-1-negative counterpart in Japan. J Med Virol. 2001; 64(4): 435-40[PubMed]
  • 23. Schaefer S. Hepatitis B virus genotypes in Europe. Hepatol Res. 2007; 37-6[DOI][PubMed]
  • 24. Pourkarim MR, Van Ranst M. Guidelines for the detection of a common source of hepatitis B virus infections. Hepat Mon. 2011; 11(10): 783-5[DOI][PubMed]
  • 25. Amini-Bavil-Olyaee S, Pourkarim MR, Schaefer S, Mahboudi F, Van Ranst M, Adeli A, et al. Single-step real-time PCR to quantify hepatitis B virus and distinguish genotype D from non-D genotypes. J Viral Hepat. 2011; 18(4): 300-4[DOI][PubMed]
  • 26. Wu JF, Chang MH. Natural history of chronic hepatitis B virus infection from infancy to adult life - the mechanism of inflammation triggering and long-term impacts. J Biomed Sci. 2015; 22: 92[DOI][PubMed]
  • 27. Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology. 2001; 34(4 Pt 1): 617-24[DOI][PubMed]
  • 28. Tran TT, Gordon SC, Fung S, Dinh P, Yee L, Martins EB, et al. Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trials. PLoS One. 2015; 10(3)[DOI][PubMed]
  • 29. Lindh M, Horal P, Dhillon AP, Norkrans G. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat. 2000; 7(4): 258-67[PubMed]
  • 30. Oommen PT, Wirth S, Wintermeyer P, Gerner P. Relationship between viral load and genotypes of hepatitis B virus in children with chronic hepatitis B. J Pediatr Gastroenterol Nutr. 2006; 43(3): 342-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments